脓毒症预后相关生物标志物的研究进展  

Advances in the Study of Prognosis-Related Biomarkers in Sepsis

作　　者：屈峻杰 石晓卉[2] 

机构地区：[1]新疆医科大学研究生院,新疆 乌鲁木齐 [2]新疆维吾尔自治区人民医院重症医学科,新疆 乌鲁木齐

出　　处：《临床医学进展》2023年第9期14810-14817,共8页Advances in Clinical Medicine

摘　　要：脓毒症是人体对感染的免疫反应失调而导致的全身多脏器功能障碍,在重症监护住院患者中具有高发病率、高死亡率等特点。因此早期评估脓毒症患者预后并及时干预治疗对降低患者死亡率、减少患者住院时间及住院费用等具有重要意义。近年来,寻找简单、可靠的早期生物标志物,早期评估脓毒症患者不良预后,是目前临床中关注的热点问题之一,该文就近年用于评估脓毒症患者预后的生物标志物的研究进展进行综述。Sepsis is a systemic multiple organ dysfunction caused by the imbalance of immune response to in-fection. Sepsis has the characteristics of high morbidity and mortality in intensive care inpatients. Therefore, early evaluation of the prognosis of patients with sepsis and timely intervention treat-ment is of great significance to reduce mortality, hospitalization time and hospitalization costs. At present, there are many biomarkers that can be used to evaluate the prognosis of patients with sepsis, and these biomarkers have their own advantages in clinical application. This paper reviews the research progress of biomarkers used to evaluate the prognosis of patients with sepsis in recent years.

关 键 词：脓毒症 生物标志物 预后 

分 类 号：R47[医药卫生—护理学]